The story of Viagra offers a intricate case study for investors eyeing pharma. While first sales were explosive, recent patent expiration and the rise of alternative versions have considerably impacted earnings. In https://hannasgps547842.blog-a-story.com/22802057/viagra-and-big-pharma-a-precarious-investment